Table 3.
The correlation between multidrug-resistant, extensively drug-resistant, and pan-drug-resistant and CRISPR/Cas systems prevalent in isolates of P. aeruginosa.
| MDR/XDR/PDR | CRISPR/Cas Positive No. (%) |
CRISPR/Cas Negative No. (%) |
Number of strains |
|---|---|---|---|
| MDR1 | 0 (0.0) | 20 (100.0) | 20 (20.0 %) |
| XDR2 | 2 (18.2) | 9 (81.8) | 11 (11.0 %) |
| PDR2 | 2 (9.1) | 20 (90.9) | 22 (22.0 %) |
| CR3 | 4 (12.1) | 29 (87.9) | 33 (33 %) |
MDR: Multidrug resistance; XDR: Extensively drug-resistance; PDR: Pan-drug resistance; 1 All MDR isolates produced ESBLs; 2 The XDR and PDR categories mainly comprised metallo-β-lactamase producers, carbapenemases (CRs); while 3 represents the combination of PDR and XDR.